Physician profile
Robert R Gray
NPI 1447407655
$422,378.06
in general payments reported to CMS, 2019-2025
14 companies · $75K in 2025
The $75K reported for 2025 was more than what 99% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $15K · 2021: $58K · 2022: $77K · 2023: $91K · 2024: $67K · 2025: $75K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $78K · Education: $67K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $64K · Travel and Lodging: $11K · Food and Beverage: $11K · Consulting Fee: $2,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $78,229.17 |
| Education | $66,800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $63,900.00 |
| Travel and Lodging | $11,316.13 |
| Food and Beverage | $10,793.76 |
| Consulting Fee | $2,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Skeletal Dynamics INC | $410,300.99 | 2019-2025 | Geminus, Ijs, Align |
| Trice Medical, INC. | $4,836.80 | 2022-2025 | |
| Biotissue Holdings INC. | $3,278.50 | 2019-2021 | |
| Axogen | $1,163.09 | 2019-2025 | Avance Nerve Graft |
| Globus Medical, INC. | $1,114.86 | 2022-2023 | Clavicular Fracture Fixation |
| Zimmer Biomet Holdings, INC. | $722.17 | 2019 | |
| Checkpoint Surgical, INC | $331.02 | 2024 | Checkpoint Stimulators |
| Tenex Health INC. | $260.22 | 2021 | |
| Alafair Biosciences, INC. | $176.09 | 2025 | Versawrap |
| Depuy Synthes Sales INC. | $102.87 | 2019 | |
| Smith+Nephew, INC. | $31.90 | 2022 | |
| Endo Pharmaceuticals INC. | $23.96 | 2023 | Xiaflex |
| Joint Active Systems, INC. | $19.95 | 2022 | |
| Bioventus LLC | $15.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.